Showing results (161-170 of 830) with videos related to

Sort By:
Pageof 83
Pharmacogenetics|September 30, 2004
The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patientsReinhold Kreutz, Heiko Zürcher, Silke Kain, et al.
Pharmacogenetics|October 12, 2004
Maternal/newborn GSTT1 null genotype contributes to risk of preterm, low birthweight infantsTomoko Nukui, Richard D Day, Cynthia S Sims, et al.
Pharmacogenetics|October 12, 2004
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult CaucasiansKerri A Schoedel, Ewa B Hoffmann, Yushu Rao, et al.
Pharmacogenetics|April 30, 2004
Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosisCyril Flamant, Alexandra Henrion-Caude, Pierre-Yves Boëlle, et al.
Pharmacogenetics|May 7, 2004
Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis studySuetnee Chen, Natalia Tsybouleva, Christie M Ballantyne, et al.
Pharmacogenetics|November 27, 2004
The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholaminesKarl La Rosée, Michael Huntgeburth, Stephan Rosenkranz, et al.
Pharmacogenetics|November 27, 2004
Functionality of allelic variations in human alcohol dehydrogenase gene family: assessment of a functional window for protection against alcoholismShou-Lun Lee, Jan-Olov Höög, Shih-Jiun Yin
Pharmacogenetics|November 27, 2004
Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)Megumi Iwai, Hiroshi Suzuki, Ichiro Ieiri, et al.
Pharmacogenetics|November 24, 1998
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypesH Takahashi, T Kashima, S Nomoto, et al.
Pharmacogenetics|November 24, 1998
Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liverM Shou, M Martinet, K R Korzekwa, et al.
Pageof 83